A comprehensive view of McKesson Corp.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AstraZeneca picks Biologics by McKesson as a specialty pharmacy provider for TRUQAP, an FDA-approved oral treatment for certain types of advanced or metastatic breast cancer
Published: December 04, 2023 by ENP Newswire
U.S. Patent and Trademark Office Publishes Mckesson Corp's Patent Application for Methods and Systems for Association Rule Mining
Published: November 24, 2023 by Metal & Mining Patent News
Takeda selects Biologics by McKesson as specialty pharmacy provider for FDA-approved oral targeted therapy Fruzaqla for adults with metastatic colorectal cancer; the treatment is the first targeted therapy for the condition in over a decade
Published: November 15, 2023 by McKesson Corp.
McKesson Corporation - Material Agreement - Form 8-K
Published: November 07, 2023 by U.S. Markets (Alternative Disclosure) via PUBT
MCKESSON CORP - (8-K) - Disclosing Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Published: November 07, 2023 by SEC Edgar Filings

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count